Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Parkinson 25. February 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2828  Previews Next
   
   Articles 1 - 20 / 56559  
   
Progress in the study of ion channel function, mechanisms, and mathematical modeling in Parkinson's disease.
iScience
Wang R, Zeng X, Zhang Z, Ma D.
PMID: 41732483 [PubMed]


Longitudinal Neuroimaging Reveals Divergent Clinical Associations of Glymphatic Dysfunction and Dopaminergic Degeneration in Parkinson's Disease.
Hum Brain Mapp
Liu T, Shen Y, Bai Y, Gao S, Meng N, Wei W, Roberts N, Wang M.
PMID: 41731626 [PubMed - indexed for MEDLINE]


In-person when necessary and available, remotely when possible - How telemedicine can support palliative care for persons with Parkinson's disease: a qualitative study.
BMC Palliat Care
van den Bergh R, Muente C, van Barschot P, Bloem BR, Meinders MJ.
PMID: 41731460 [PubMed - as supplied by publisher]


Relationship between frailty and disease progression in Parkinson's disease: a 3-year longitudinal study.
Geroscience
Costanzo M, Canevelli M, De Bartolo MI, Valletta M, Marchet F, Blasi MT, Leodori G, Conte A, Bruno G, Fabbrini G, Belvisi D.
PMID: 41731291 [PubMed - as supplied by publisher]


Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study.
Mov Disord
Papagiannakis N, Koros C, Simitsi AM, Stefanis L, and The Parkinson's Progression Markers Initiative.
PMID: 41730696 [PubMed - as supplied by publisher]


Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
Mov Disord Clin Pract
Vidal ÁS, Santos-García D, de Deus Fonticoba T, Jesús S, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Vara JH, Cabo I, Manzanares LL, Aramburu IG, Rivera AA, Mayordomo VG, Nogueira V, García-Soto JD, Borrué C, Vila BS, Sauco MÁ, Mir P, COPPADIS Study Group.
PMID: 41730672 [PubMed - as supplied by publisher]


How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review.
Neuroscience
Ren B, Yan H, Han C, Sun S, Wang D, Xu Y, Xie J.
PMID: 41730497 [PubMed - as supplied by publisher]


Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
Neuroscience
Panda SP, Saraswat N, Singh V.
PMID: 41730496 [PubMed - as supplied by publisher]


Parkinson's Disease Biomarkers: Bridging the Gap Between Diagnosis and Treatment.
Behav Brain Res
Chakkarwar VA, Kulkarni YA.
PMID: 41730457 [PubMed - as supplied by publisher]


Trustworthy AI for medical decisions: Adversarially robust and fair machine learning prediction for Parkinson's disease.
PLoS One
Muhammad J, Ghergherehchi M, Ali S, Seung Song H, Rahim N.
PMID: 41729985 [PubMed - indexed for MEDLINE]


Multimodal Machine Learning and Deep Learning Approaches for Parkinson's Disease Diagnosis: A Comprehensive Survey.
Clin EEG Neurosci
Ahmed AN, Mohammed AS, Yousif Potrus M.
PMID: 41729683 [PubMed - as supplied by publisher]


Causal Effects Between Antibody-Mediated Immune Responses and Parkinson's Disease: Insights from Genetic Studies.
Cureus
Yu F, Cai R.
PMID: 41728547 [PubMed]


Predictive modeling of vocal biomarkers for the diagnosis of Parkinson's disease.
Cogn Neurodyn
Emegano DI, Mustapha MT, Isaac EP, Ozsahin I, Uzun B, Ozsahin DU.
PMID: 41728211 [PubMed]


PARQ: A Complexity-Consensus Aware Automatic Assessment of Motor Disease Severity in Parkinson's Disease.
Res Sq
Chakraborty I, Trushenski K, Khan SS, Taneff Y, Tarakad A, Anandan C, Bellows ST, Yilmaz AY, Balakrishnan G, Vanegas-Arroyave N, Sabharwal A.
PMID: 41727589 [PubMed]


Microglia heterogeneity and therapeutic strategies in Parkinson's disease.
Front Immunol
Tian J, Liu X, Wang Z, Shi X, Dai C, Yang L.
PMID: 41727462 [PubMed - indexed for MEDLINE]


Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation.
Neurol Ther
Stocchi F, Knecht M, Marjanovic I, Wach A, Kopra J, Kulisevsky J.
PMID: 41724884 [PubMed - as supplied by publisher]


White matter alterations in right-onset versus left-onset Parkinson's disease in an early stage.
Behav Brain Res
Li X, Tan C, Cai S, Liu Q, Wang M, Liu Y, Yuan J, Tang Y, Niu Y, Huang C, He W, Shen Q, Liao H.
PMID: 41724446 [PubMed - as supplied by publisher]


Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study.
EBioMedicine
Zhou H, Wang Z, Tan Z, Deng B, Yang W, Huang Z, Guo X, Li J, Wang X, Yu Y, Deng C, Zheng W, Zhang X, Chen X, Yue J, Yang C, Cui X, Poplawska-Domaszewicz K, Chaudhuri KR, Zhou Z, Xiao B, Chan LL, Foo JN, Tan EK, Wang Q.
PMID: 41724112 [PubMed - as supplied by publisher]


Assessment of Angiopep-2 targeting intracerebral α-synuclein aggregates in a PFF-induced rat model of Parkinson's disease based on 7T CEST-MRI.
Brain Res Bull
Lai L, Chen B, Xu L, Wu M, Wang R, Zhuang Z, Dong G, Qi D, Lin K, Li D, He Y, Lin Y, Sun S, Zheng X, Chen Y, Jia Y, Mikulis DJ, Wu E, Zhang X, Zhou T, Guan J, Wu R.
PMID: 41722787 [PubMed - as supplied by publisher]


Adaptive deep brain stimulation in Parkinson's disease.
Lancet
de Neeling MGJ, Keulen BJ, Stam MJ, van Wijk BCM, Beudel M.
PMID: 41722605 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 56559    Page 1 of 2828  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1